Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

I didn't read it that way, but I can only hope you are correct. IMO, all bonuses and salaries too from here on out should be based on Lymphoseek sales and newly achieved milestones related to the rest of the pipeline. No one at Navidea deserves even $200K annually based on the absolute nonsense we have seen since September 2013.

A new short interest report should be available tonight. FWIW, I expect at least another 500,000 share increase. All of the short covering that started back in April of 2013 that brought the short interest down from 25 million shares to 18 million seems to be getting reshorted to cap the price at present.

Never forget that regardless of company rationales, explanations, and necessities, $100 million in market cap was thrown away to raise $30 million. If I had my way...I can't say anymore... :)